Nahata M C, DeBolt S L, Powell D A
Dev Pharmacol Ther. 1982;4(3-4):117-23. doi: 10.1159/000457400.
68 patients (from newborns to 18 years of age) were studied prospectively for adverse effects associated with methicillin, nafcillin and oxacillin. Hematologic, liver and renal function tests were monitored before and during therapy. 3 of 28 patients receiving methicillin developed eosinophilia within 5-8 days. Of 32 patients on nafcillin, 2 had neutropenia within 4-13 days, 3 had eosinophilia within 1-4 days and 1 elevated liver enzymes on day 3. Of 8 patients receiving oxacillin, 1 developed neutropenia on day 11 and another showed elevation of liver enzymes on day 15. All abnormalities were reversible with the discontinuation of therapy. Appropriate laboratory tests should be monitored to detect an occurrence of adverse reaction to methicillin, nafcillin and oxacillin.
对68名患者(从新生儿到18岁)进行了前瞻性研究,以观察与甲氧西林、萘夫西林和苯唑西林相关的不良反应。在治疗前和治疗期间监测血液学、肝功能和肾功能检查。28名接受甲氧西林治疗的患者中有3名在5 - 8天内出现嗜酸性粒细胞增多。在32名使用萘夫西林的患者中,2名在4 - 13天内出现中性粒细胞减少,3名在1 - 4天内出现嗜酸性粒细胞增多,1名在第3天出现肝酶升高。8名接受苯唑西林治疗的患者中,1名在第11天出现中性粒细胞减少,另1名在第15天出现肝酶升高。所有异常在停药后均可逆转。应进行适当的实验室检查,以检测对甲氧西林、萘夫西林和苯唑西林不良反应的发生情况。